Philadelphia Trust Company’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$518K	Hold	7,500	–	–	0.04%	150
2025 Q1	$521K	Hold	7,500	–	–	0.04%	149
2024 Q4	$645K	Hold	7,500	–	–	0.05%	138
2024 Q3	$893K	Hold	7,500	–	–	0.06%	127
2024 Q2	$1.07M	Hold	7,500	–	–	0.08%	111
2024 Q1	$963K	Hold	7,500	–	–	0.08%	119
2023 Q4	$776K	Hold	7,500	–	–	0.07%	123
2023 Q3	$682K	Hold	7,500	–	–	0.07%	129
2023 Q2	$607K	Hold	7,500	–	–	0.06%	143
2023 Q1	$597K	Hold	7,500	–	–	0.06%	142
2022 Q4	$508K	Hold	7,500	–	–	0.05%	150
2022 Q3	$374K	Hold	7,500	–	–	0.04%	168
2022 Q2	$418K	Hold	7,500	–	–	0.04%	157
2022 Q1	$416K	Hold	7,500	–	–	0.03%	178
2021 Q4	$420K	Hold	7,500	–	–	0.03%	183
2021 Q3	$360K	Hold	7,500	–	–	0.03%	188
2021 Q2	$314K	Hold	7,500	–	–	0.02%	202
2021 Q1	$253K	Hold	7,500	–	–	0.02%	204
2020 Q4	$262K	Hold	7,500	–	–	0.02%	193
2020 Q3	$260K	Buy	+7,500	New	+$260K	0.03%	180
2015 Q3	–	Sell	-510	Closed	-$4.66K	–	179
2015 Q2	$4.66K	Buy	+510	New	+$4.66K	0.02%	166